GraniteShares YieldBOOST Biotech ETF
ETFYour view on BIOY
GraniteShares YieldBOOST Biotech ETF
ETFGraniteSharesSentiment
AUM (USD)
$851.32K
Expense Ratio
1.07%
Holdings
0
Sentiment
Overview for GraniteShares YieldBOOST Biotech ETF
- Fund Type
- ETF
- Fund Issuer
- GraniteShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- May 5, 2026
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- GraniteShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- May 5, 2026
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- GraniteShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- May 5, 2026
- Domicile
- US
About this fund
The GraniteShares YieldBOOST Biotech ETF, an exchange-traded fund launched by GraniteShares Inc. under the umbrella of the GraniteShares ETF Trust, is managed by GraniteShares Advisors LLC. This U.S.-domiciled fund primarily allocates capital to the public stock markets within th…
BIOY Stock Price
Key Facts
EquityExpense Ratio
1.07%
AUM
$851.32K
Fund Details
Expense Ratio
1.07%
Assets Under Management
$851.32K
NAV
$21.28 USD
Average Volume
1.8K
Inception Date
May 5, 2026
Asset Class
Equity
Fund Issuer
GraniteShares
Domicile
US
ISIN
US38747T6414
CUSIP
38747T641
NAV Currency
USD
Expense Ratio
1.07%
Assets Under Management
$851.32K
NAV
$21.28 USD
Average Volume
1.8K
Inception Date
May 5, 2026
Asset Class
Equity
Fund Issuer
GraniteShares
Domicile
US
ISIN
US38747T6414
CUSIP
38747T641
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.